The typhus illnesses are a set of acute fever-causing infections produced by obligate intracellular bacteria of the genera Rickettsia and Orientia. Three diseases dominate in humans: epidemic typhus (Rickettsia prowazekii), murine or flea-borne typhus (Rickettsia typhi), and scrub typhus (chiefly Orientia tsutsugamushi). They overlap clinically, sharing fever, headache, muscle pain, rash, and the potential for multisystem involvement, yet they differ markedly in vector, animal reservoir, geographic range, and epidemiological setting. Epidemic typhus follows body-louse infestation in crowded, impoverished, war-affected, or displaced populations. Murine typhus spreads through contamination of skin with infected flea feces and is tied to rodents and other animal hosts. Scrub typhus is passed on by larval trombiculid mites and is a leading cause of acute undifferentiated fever across the Asia-Pacific region, including the Indian subcontinent. Diagnosis is difficult because the early picture resembles malaria, dengue, leptospirosis, enteric fever, common viral infections, and other rickettsioses. Antibody tests may be negative early and may remain positive after past infection, whereas polymerase chain reaction (PCR) can confirm infection sooner when suitable samples are taken. Since late treatment raises the risk of serious complications, therapy is often started empirically when suspicion is high. Doxycycline is the cornerstone drug for all three diseases; azithromycin and a few other agents serve in specific situations. Control rests on vector management, personal protection, sanitation, prompt recognition, effective treatment, and public-health surveillance. Persisting gaps include under-diagnosis, restricted access to molecular testing, the antigenic variability of Orientia, sporadic reports of reduced drug responsiveness, and weak surveillance. This review consolidates present knowledge on the principal typhus diseases and outlines priorities for diagnostics, therapy, prevention, and research.
No takes yet. Share an insight, caveat, or question.
Rajeev Kumar Jha (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: